Regarding clinical stages, patients at the MCI stage, but not those at the dementia stage, had significantly higher levels of CSF PDGFRβ than NC with a medium effect size (Cohen's d = 0.55 [CI95% 0.066 to 1.0], P = 0.025, Fig. 1a). This evidence concerns the gene PDGFRB and dementia.